Kawabata N, Yano K, Ohno H, Nakashima T
Central Research Laboratory, SS Pharmaceutical Co., Ltd., Narita, Japan.
Jpn J Pharmacol. 1990 Dec;54(4):487-90. doi: 10.1254/jjp.54.487.
Higher plasma concentrations of 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT) were obtained after administration of FT (100 mg/kg, i.v.) combined with L-cysteine (CySH, 500 mg/kg, p.o.). The volume of distribution (Vd) and body fluid volumes significantly decreased. These results suggest that the increase of the plasma concentrations of FT can be attributed to the decrease of the Vd of FT, which is considered to be based on the decrease of body fluid volumes by the combined administration of CySH.
静脉注射1-(四氢-2-呋喃基)-5-氟尿嘧啶(FT,100mg/kg)联合口服L-半胱氨酸(CySH,500mg/kg)后,血浆中FT浓度升高。分布容积(Vd)和体液量显著降低。这些结果表明,FT血浆浓度的升高可归因于FT分布容积的降低,这被认为是由于联合给予CySH导致体液量减少所致。